Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2022 Jul;48(7):1888-1896.
doi: 10.1111/jog.15238. Epub 2022 Apr 5.

Adjuvant chemoradiotherapy versus chemotherapy alone in stage III endometrial cancer: A systematic review and meta-analysis

Guo Zhang  1 , He Li  1 , Zhao Tian  1 , Xiaoping Li  1 , Zhiqi Wang  1 , Xudong Liang  1 , Yue Wang  1 , Xiaoyan Shen  1 , Jianliu Wang  1
Affiliations
Meta-Analysis

Adjuvant chemoradiotherapy versus chemotherapy alone in stage III endometrial cancer: A systematic review and meta-analysis

Guo Zhang et al. J Obstet Gynaecol Res. 2022 Jul.

Abstract

Objective: To discuss the impact of chemoradiotherapy (CRT) on the survival of patients with stage III endometrial cancer (EC) compared with chemotherapy (CT) alone.

Methods: Articles involving adjuvant CRT versus CT on survival in stage III EC were retrieved from PubMed and EMBASE. Hazard ratios (HRs) of overall survival (OS) and relapse-free survival (RFS) were collected and pooled, and publication bias was measured by Begg's and Egger's test. Quality of researches was measured by the Newcastle-Ottawa scale and the modified Jadad scale.

Results: Eleven were included in the statistical analysis. A significant advantage of CRT over CT on OS was shown (HR 0.59, 95% CI 0.49-0.70). Further subgroup analysis suggested the advantage was mostly associated with stage IIIC (HR 0.63, 95% CI 0.52, 0.76]). A similar result favoring CRT was also reached on RFS (HR 0.66, 95% CI 0.47-0.93). No significant publication bias was observed.

Conclusion: CRT was associated with a better OS and RFS than CT alone in stage III EC patients.

Keywords: chemoradiotherapy; chemotherapy; endometrial cancer; overall survival; relapse-free survival.

PubMed Disclaimer

References

    1. Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115-32.
    1. National Comprehensive Cancer Network (NCCN). NCCN clinical practice guidelines in oncology. Uterine Neoplasms Version 1. 2022. 2021 Nov 4; National Comprehensive Cancer Network. Available from: http://www.nccn.org/professionals/physician_gls/pdf/uterine.pdf.
    1. Amant F, Mirza MR, Koskas M, Creutzberg CL. Cancer of the corpus uteri. Int J Gynecol Obstet. 2018;143(S2):37-50.
    1. Oremus M, Wolfson C, Perrault A, Demers L, Momoli F, Moride Y. Interrater reliability of the modified Jadad quality scale for systematic reviews of Alzheimer's disease drug trials. Dement Geriatr Cogn Disord. 2001;12(3):232-6.
    1. Wells GASB, O'Conell D, Peterson J, Welch V, Losos M, Tugwell P. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. UK: University of Liverpool. 2014.

LinkOut - more resources